{
    "medicine_id": "9f3b628735cdb1272c40b7fe2bbdb0d1331b3a69",
    "platform_id": "DB00666",
    "metadata": {
        "name": "Synarel 2 mg 1mL Spray metered",
        "composition": "2 mg 1mL Nafarelin",
        "clinical_particulars": {
            "therapeutic_indications": "For treatment of central precocious puberty true precocious puberty GnRH dependent precocious precocity complete isosexual precocity in children of both sexes and for the treatment of endometriosis",
            "contraindications": {
                "disease": "In experimental animals a single subcutaneous administration of up to 60 times the recommended human dose on a micro g kg basis not adjusted for bioavailability had no adverse effects At present there is no clinical evidence of adverse effects following overdosage of GnRH analogs",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Nafarelin is a potent agonistic analog of gonadotropin releasing hormone GnRH At the onset of administration nafarelin stimulates the release of the pituitary gonadotropins luteinizing hormone LH and follicle stimulating hormone FSH resulting in a temporary increase of gonadal steroidogenesis Repeated dosing abolishes the stimulatory effect on the pituitary gland Twice daily administration leads to decreased secretion of gonadal steroids by about 4 weeks consequently tissues and functions that depend on gonadal steroids for their maintenance become quiescent After nafarelin therapy is discontinued pituitary and ovarian function normalize and estradiol serum concentrations increase to pretreatment levels Recurrences of endometriosis are frequent after cessation of any hormonal therapy or surgery that leaves the ovaries and or uterus intact",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB09066",
                        "description": "The therapeutic efficacy of Corifollitropin alfa can be increased when used in combination with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB09277",
                        "description": "Nafarelin may decrease effectiveness of Choline C 11 as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB00089",
                        "description": "Nafarelin may decrease effectiveness of Capromab pendetide as a diagnostic agent"
                    },
                    {
                        "drugbank-id": "DB00007",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Leuprolide is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00052",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Somatotropin is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Infliximab is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00080",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Daptomycin is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Cyclosporine is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00175",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Pravastatin is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00181",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Baclofen is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00203",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Sildenafil is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00224",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Indinavir is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00227",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Lovastatin is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Cladribine is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00252",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Phenytoin is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00282",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Pamidronic acid is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00358",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Mefloquine is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00382",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Tacrine is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00389",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Carbimazole is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00439",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Cerivastatin is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00440",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Trimethoprim is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Betamethasone is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00471",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Montelukast is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Zidovudine is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00501",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Cimetidine is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00503",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ritonavir is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00528",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Lercanidipine is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00537",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ciprofloxacin is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Vincristine is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Propylthiouracil is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Methotrexate is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00584",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Enalapril is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00585",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nizatidine is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00602",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Ivermectin is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00608",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Chloroquine is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Triamcinolone is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00627",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Niacin is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00630",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Alendronic acid is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00636",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Clofibrate is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00641",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Simvastatin is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00649",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Stavudine is combined with Nafarelin"
                    },
                    {
                        "drugbank-id": "DB00681",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Amphotericin B"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Mycophenolate mofetil"
                    },
                    {
                        "drugbank-id": "DB00704",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Naltrexone"
                    },
                    {
                        "drugbank-id": "DB00709",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Lamivudine"
                    },
                    {
                        "drugbank-id": "DB00710",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Ibandronate"
                    },
                    {
                        "drugbank-id": "DB00818",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Propofol"
                    },
                    {
                        "drugbank-id": "DB00857",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Terbinafine"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Penicillamine"
                    },
                    {
                        "drugbank-id": "DB00863",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Ranitidine"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Tacrolimus"
                    },
                    {
                        "drugbank-id": "DB00876",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Eprosartan"
                    },
                    {
                        "drugbank-id": "DB00884",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Risedronic acid"
                    },
                    {
                        "drugbank-id": "DB00887",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Bumetanide"
                    },
                    {
                        "drugbank-id": "DB00897",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Triazolam"
                    },
                    {
                        "drugbank-id": "DB00898",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Ethanol"
                    },
                    {
                        "drugbank-id": "DB00938",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Salmeterol"
                    },
                    {
                        "drugbank-id": "DB00951",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Isoniazid"
                    },
                    {
                        "drugbank-id": "DB00968",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Methyldopa"
                    },
                    {
                        "drugbank-id": "DB00982",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Isotretinoin"
                    },
                    {
                        "drugbank-id": "DB00987",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Cytarabine"
                    },
                    {
                        "drugbank-id": "DB01004",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Ganciclovir"
                    },
                    {
                        "drugbank-id": "DB01006",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Letrozole"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Sulfamethoxazole"
                    },
                    {
                        "drugbank-id": "DB01017",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Minocycline"
                    },
                    {
                        "drugbank-id": "DB01035",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Procainamide"
                    },
                    {
                        "drugbank-id": "DB01039",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Fenofibrate"
                    },
                    {
                        "drugbank-id": "DB01059",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Norfloxacin"
                    },
                    {
                        "drugbank-id": "DB01076",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Atorvastatin"
                    },
                    {
                        "drugbank-id": "DB01088",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Iloprost"
                    },
                    {
                        "drugbank-id": "DB01095",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Fluvastatin"
                    },
                    {
                        "drugbank-id": "DB01097",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Leflunomide"
                    },
                    {
                        "drugbank-id": "DB01098",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Rosuvastatin"
                    },
                    {
                        "drugbank-id": "DB01118",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Amiodarone"
                    },
                    {
                        "drugbank-id": "DB01165",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Ofloxacin"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Procarbazine"
                    },
                    {
                        "drugbank-id": "DB01197",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Captopril"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Paclitaxel"
                    },
                    {
                        "drugbank-id": "DB01232",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Saquinavir"
                    },
                    {
                        "drugbank-id": "DB01233",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Metoclopramide"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Dexamethasone"
                    },
                    {
                        "drugbank-id": "DB01241",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Gemfibrozil"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Docetaxel"
                    },
                    {
                        "drugbank-id": "DB01393",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Bezafibrate"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Colchicine"
                    },
                    {
                        "drugbank-id": "DB02703",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Fusidic acid"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Trabectedin"
                    },
                    {
                        "drugbank-id": "DB06693",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Mevastatin"
                    },
                    {
                        "drugbank-id": "DB06817",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Raltegravir"
                    },
                    {
                        "drugbank-id": "DB08860",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Pitavastatin"
                    },
                    {
                        "drugbank-id": "DB08983",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Etofibrate"
                    },
                    {
                        "drugbank-id": "DB09055",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Acipimox"
                    },
                    {
                        "drugbank-id": "DB09064",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Ciprofibrate"
                    },
                    {
                        "drugbank-id": "DB09270",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Ubidecarenone"
                    },
                    {
                        "drugbank-id": "DB09289",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Tianeptine"
                    },
                    {
                        "drugbank-id": "DB12554",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Mebeverine"
                    },
                    {
                        "drugbank-id": "DB13293",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Ipecac"
                    },
                    {
                        "drugbank-id": "DB13393",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Emetine"
                    },
                    {
                        "drugbank-id": "DB13433",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Simfibrate"
                    },
                    {
                        "drugbank-id": "DB13460",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Ronifibrate"
                    },
                    {
                        "drugbank-id": "DB13780",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Aluminium clofibrate"
                    },
                    {
                        "drugbank-id": "DB13849",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Clofibride"
                    },
                    {
                        "drugbank-id": "DB13873",
                        "description": "The risk or severity of myopathy rhabdomyolysis and myoglobinuria can be increased when Nafarelin is combined with Fenofibric acid"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}